IFM Investors Pty Ltd Grows Holdings in Axon Enterprise, Inc (NASDAQ:AXON)

IFM Investors Pty Ltd grew its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 3.3% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 14,795 shares of the biotechnology company's stock after acquiring an additional 479 shares during the period. IFM Investors Pty Ltd's holdings in Axon Enterprise were worth $7,781,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Fourth Dimension Wealth LLC bought a new position in Axon Enterprise during the fourth quarter worth $30,000. Bartlett & CO. Wealth Management LLC raised its stake in Axon Enterprise by 132.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock worth $31,000 after buying an additional 33 shares during the last quarter. Alpine Bank Wealth Management bought a new position in Axon Enterprise during the first quarter worth $40,000. Elequin Capital LP bought a new position in Axon Enterprise during the fourth quarter worth $46,000. Finally, CoreFirst Bank & Trust bought a new position in Axon Enterprise during the fourth quarter worth $59,000. Institutional investors own 79.08% of the company's stock.

Insider Activity

In other news, Director Michael Garnreiter sold 5,913 shares of Axon Enterprise stock in a transaction dated Wednesday, June 4th. The shares were sold at an average price of $760.00, for a total transaction of $4,493,880.00. Following the completion of the transaction, the director directly owned 17,740 shares in the company, valued at $13,482,400. This trade represents a 25.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Brittany Bagley sold 3,400 shares of Axon Enterprise stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $700.00, for a total transaction of $2,380,000.00. Following the transaction, the chief financial officer owned 131,833 shares of the company's stock, valued at $92,283,100. This represents a 2.51% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 44,642 shares of company stock valued at $30,500,428. 4.40% of the stock is currently owned by insiders.

Analyst Ratings Changes

AXON has been the subject of a number of analyst reports. Craig Hallum downgraded shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. The Goldman Sachs Group lifted their target price on shares of Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research note on Wednesday, May 14th. Needham & Company LLC lifted their price target on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a research note on Thursday, May 8th. Bank of America lifted their price target on shares of Axon Enterprise from $750.00 to $895.00 and gave the company a "buy" rating in a research note on Wednesday, June 4th. Finally, Barclays lifted their price target on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a research note on Friday, May 9th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $699.55.

Axon Enterprise Stock Up 2.7%

Shares of NASDAQ AXON traded up $20.93 during mid-day trading on Friday, reaching $795.48. 268,670 shares of the company's stock traded hands, compared to its average volume of 540,118. The stock has a market cap of $61.93 billion, a P/E ratio of 192.14, a PEG ratio of 91.57 and a beta of 1.29. The business has a 50-day simple moving average of $736.97 and a 200 day simple moving average of $635.97. Axon Enterprise, Inc has a 1-year low of $279.02 and a 1-year high of $830.21. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.83 and a quick ratio of 2.62.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.34 by $0.07. The firm had revenue of $603.63 million during the quarter, compared to analysts' expectations of $585.67 million. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. The business's revenue was up 31.3% on a year-over-year basis. During the same period last year, the company earned $1.15 earnings per share. On average, analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.